Success Metrics

Clinical Success Rate

50.0%

Based on 1 completed trials

Completion Rate

50%(1/2)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(25%)

Phase Distribution

Ph phase_2

25%

Ph phase_3

25%

Ph phase_4

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

1(33.3%)

Phase 3Large-scale testing

1(33.3%)

Phase 4Post-market surveillance

1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(1)

Terminated(2)

Other(1)

Detailed Status

Withdrawn1

Terminated1

Completed1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (33.3%)

Phase 31 (33.3%)

Phase 41 (33.3%)

Trials by Status

withdrawn125%

terminated125%

completed125%

unknown125%

Recent Activity

0 active trials

Showing 4 of 4

unknown

Breast Cancer Treatment Based on Organ-like Culture

NCT03925233

withdrawnphase_4

Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer

NCT03238703

completedphase_3

Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy

NCT00129142

terminatedphase_2

Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer

NCT00437359

Clinical Trials (4)

Showing 4 of 4 trials

NCT03925233

Breast Cancer Treatment Based on Organ-like Culture

Unknown

NCT03238703Phase 4

Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer

Withdrawn

NCT00129142Phase 3

Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy

Completed

NCT00437359Phase 2

Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer

Terminated

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4